Supplier log in
Invitation for Registration of Interest for Listing Agreements for Implanted Cardioverter Defibrillators, Pacemakers and Associated Products
Details
|
Tender Closed
|
|
| RFx ID : | 24097907 |
| Tender Name : | Invitation for Registration of Interest for Listing Agreements for Implanted Cardioverter Defibrillators, Pacemakers and Associated Products |
| Reference # : | |
| Open Date : | Tuesday, 16 March 2021 12:30 PM (Pacific/Auckland UTC+13:00) |
| Close Date : | Tuesday, 13 April 2021 5:00 PM (Pacific/Auckland UTC+12:00) |
| Tender Type : | Registration of Interest (ROI) |
| Tender Coverage : | Sole Agency [?] |
| Categories : |
|
| Regions: |
|
| Required Pre-qualifications : | None |
| Contact : |
Sam Bright sam.bright@pharmac.govt.nz . |
| Alternate Physical Delivery Address : | |
| Alternate Physical Fax Number : | |
| Agency Address : | |
In coordination with PHARMAC, NZ Health Partnerships (“NZHP”) has previously released Requests for Proposals ("RFP") for ranges of medical devices which PHARMAC may list on the Pharmaceutical Schedule.
The intent was that PHARMAC listing agreements could be entered in appropriate cases without a further substantive RFP submission from suppliers that participated in the NZHP process.
PHARMAC now invites Registrations of Interest (“ROI”) for the supply of Implanted Cardioverter Defibrillators, Pacemakers and Associated Products from suppliers for consideration for listing on the Pharmaceutical Schedule.
Please note this includes but is not limited to those suppliers who currently have contracts with or are in contract negotiations with NZHP for Implanted Cardioverter Defibrillators, Pacemakers and associated products medical devices.
Suppliers that did not submit proposals to the NZHP RFP for these devices are required to provide more extensive information in response to this ROI.
This Invitation for ROIs incorporates the following schedules:
· Schedule 1 sets out the background to the Invitation and description of the ROIs sought;
· Schedule 2 describes the process that PHARMAC expects to follow in relation to the Invitation;
· Schedule 3 sets out the information that should be included in or form part of the ROI; and
· Schedule 4 contains the ROI proposal form in which you are to provide details of your submission.
If you wish to submit a ROI in response to the Invitation, please submit via GETS no later than 5.00pm 13 April 2021
If you have any questions about this Invitation, please post these on GETS. Responses to all questions will be published on GETS.
PHARMAC looks forward to receiving your ROI.
This tender has been completed.
Further information:
Evaluation has been completed, respondents have been advised of the outcome of their submission to this ROI.
As this is a panel arrangement with no minimum spend value, there is no contract $ value to post.
Date RFx was completed/updated:
Wednesday, 14 April 2021 9:03 AM (Pacific/Auckland UTC+12:00)
